KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Current Assets: 2009-2025

Historic Current Assets for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Sep 2025 value amounting to $3.8 billion.

  • Jazz Pharmaceuticals' Current Assets fell 14.45% to $3.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year decrease of 14.45%. This contributed to the annual value of $4.6 billion for FY2024, which is 34.74% up from last year.
  • Latest data reveals that Jazz Pharmaceuticals reported Current Assets of $3.8 billion as of Q3 2025, which was up 12.10% from $3.4 billion recorded in Q2 2025.
  • Jazz Pharmaceuticals' 5-year Current Assets high stood at $4.6 billion for Q4 2024, and its period low was $2.5 billion during Q1 2022.
  • Moreover, its 3-year median value for Current Assets was $3.5 billion (2024), whereas its average is $3.6 billion.
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 108.67% in 2021, then dropped by 21.03% in 2022.
  • Over the past 5 years, Jazz Pharmaceuticals' Current Assets (Quarterly) stood at $2.6 billion in 2021, then dropped by 0.20% to $2.6 billion in 2022, then surged by 31.82% to $3.4 billion in 2023, then surged by 34.74% to $4.6 billion in 2024, then declined by 14.45% to $3.8 billion in 2025.
  • Its Current Assets stands at $3.8 billion for Q3 2025, versus $3.4 billion for Q2 2025 and $4.1 billion for Q1 2025.